Compare Erajaya Swasembada Tbk. (ERAA) vs UBC Medical Indonesia Tbk. (LABS) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Erajaya Swasembada Tbk. vs UBC Medical Indonesia Tbk. — how do they compare? Erajaya Swasembada Tbk. trades at Rp362 (market cap 5.74T, 26.16M 24h volume), while UBC Medical Indonesia Tbk. trades at Rp146 (market cap 584.6B, 817.3K 24h volume). The key difference: Erajaya Swasembada Tbk. is far larger — about 9.8× UBC Medical Indonesia Tbk.'s market cap, and Erajaya Swasembada Tbk. is more actively traded (26.16M versus 817.3K). Which is the better fit depends on your goals.
| ERAA | LABS | |
|---|---|---|
Market Cap | 5.74T | 584.6B |
Volume | 26.16M | 817.3K |
Lot | 261.63K | 8.17K |
Turnover | 9.41B | 120.01M |
Average Price | 359.75 | 146.84 |
Value | 9.41B | 120.01M |
Indicative Equilibrium Price | 362 | 146 |
Indicative Equilibrium Volume | 1.96K | 59 |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Erajaya Swasembada Tbk.
PT Erajaya Swasembada Tbk (the Company) was established in Jakarta based on Notarial Deed No.7 of Myra Yuwono, S.H., dated October 8, 1996. Erajaya Group is the official distributor for 10 international mobile communication brands and an authorised partner for major mobile operators. Recently, the Group has launched its own mobile handset under the name of Venera. In 1996, PT Erajaya Swasembada, or Erajaya, the establishment of what we know today as the Erajaya Group, was incorporated.
Read more on ERAA →About UBC Medical Indonesia Tbk.
PT UBC Medical Indonesia (the Company) was established under the framework of Law of the Republic of Indonesia No. 20 year 1994 concerning the Foreign Capital Investment, as amended by Law No. 25 year 2007 concerning the Capital Investment based on Notarial Deed No. 01 dated 4 June 2014 of Novita Puspitarini, S.H., Notary in Jakarta. The Company started its commercial activities in October 2014. The parent entity as well as the ultimate parent entity of the Company is PT Optel Investama Mulia.
Read more on LABS →
